Prof. Dr. Stefan Lichtenthaler

Professorship

Neuroproteomics

Academic Career and Research Areas

Professor Lichtenthaler conducts research on the molecular basis of neurodegenerative diseases such as Alzheimer’s disease. The goal is to gain a better understanding of these common forms of dementia, to develop new diagnostic and therapeutic approaches and to be able to better predict the possible side effects of medication. This research is carried out using biochemical and proteomic methods such as quantitative mass spectrometry.

Professor Lichtenthaler studied chemistry at the Universities of Karlsruhe, Montpellier (France) and Heidelberg. He earned his doctoral degree at ZMBH, Heidelberg University’s Center for Molecular Biology. After working as a postdoctoral researcher at Harvard University (USA) he led a junior research group at LMU Munich where he also acquired his postdoctoral teaching qualification (habilitation) for his work in the field of biochemistry. In 2009 he was appointed head of department at DZNE, the newly established German Center for Neurodegenerative Diseases. Since 2012 he has been full professor of proteomics at TUM and DZNE.

Awards

  • Alzheimer Research Award of the Hans and Ilse Breuer Foundation (2014)
  • Emmy-Noether grant recipient (1999-2001)
  • Dr. Sophie Bernthsen Prize recipient (1994)

Schmidt A, Hrupka B, van Bebber F, Kumar SS, Feng X, Tschirner SK, Aßfalg M, Müller SA, Hilger LS, Hofmann LI, Pigoni M, Jocher G, Voytyuk I, Self EL, Ito M, Hyakkoku K, Yoshimura A, Horiguchi N, Feederle R, de Strooper B, Schulte-Merker S, Lammert E, Moechars D, Schmid B, Lichtenthaler SF (2024). The Alzheimer’s disease-linked protease BACE2 cleaves VEGFR3 and modulates its signaling. J Clin Invest., e170550.

Abstract

Güner G, Aßfalg M, Zhao K, Dreyer T, Lahiri S, Lo Y, Slivinschi BI, Imhof A, Jocher G, Strohm L, Behrends C, Langosch D, Bronger H, Nimsky C, Bartsch JW, Riddell SR, Steiner H, Lichtenthaler SF (2022). Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for g-secretase activity. EMBO Mol Med, 14: e16084.

Abstract

Tüshaus J, Müller SA, Kataka ES, Zaucha J, Sebastian Monasor L, Su M, Güner G, Jocher G, Tahirovic S, Frishman D, Simons M, Lichtenthaler SF: “An optimized quantitative proteomics method establishes the cell type-resolved mouse brain secretome”. EMBO J. 2020; e105693.

Abstract

Lichtenthaler SF, Güner G: "Pathology-linked protease caught in action". Science. 2019; 363 (6428), 690-691.

Abstract

Lichtenthaler SF, Lemberg M, Fluhrer R: "Proteolytic ectodomain shedding of membrane proteins in mammals - hardware, concepts and recent developments". The EMBO Journal. 2018; 37, e99456.

Abstract

If you wish your profile to be changed or updated please contact Franz Langer.